CBT FY2025 SEC EDGAR DEF 14A #19 of 168 in industry

Cabot Corp CEO pay ratio

The CEO earned $9.3M in FY2025 against median worker pay of $54,397 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
DE
Filing date
2026-01-27
Industry
Chemicals & Pharmaceuticals
Industry rank
#19/168

Data updated August 2026

Subscribe to Cabot Corp CEO pay filing updates (RSS)

CEO-to-worker pay ratio
171:1
High (Scale: 0–1000:1)
CEO pay
$9.3M
Median worker
$54,397

Answer first

Cabot Corp's FY2025 CEO total of $9.3M ranks #575 of 1,423 complete filings; its 171:1 pay ratio ranks #377. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $54,397. Industry placement uses the FY2025 SIC-28 peer cohort (# 19 of 168, 89th percentile - top quartile of industry peers by pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#575
$9.3M of 1,423 FY2025
Ratio rank
#377
171:1 of 1,423
Industry pct
89th
top quartile of industry peers by pay ratio

How Cabot Corp ranks nationally

Cabot Corp CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$9,307,883 Top 40% higher than 60% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). Below this entry. $7,500,000–$10,000,000: 192 companies (13%). This entry sits in this band. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Cabot Corp vs. Chemicals & Pharmaceuticals peers

CEO total pay ($9.3M) against pay ratio (171:1) for Cabot Corp (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both7059855.811678091.616296327.520914563.425532799.335.0:173.3:1111.5:1149.7:1187.9:1CEO total payPay ratio (CEO : median worker)Cabot Corp, CEO total pay: 9307883 · Pay ratio (CEO : median worker): 171:1Cabot CorpHuntsman CORP, CEO total pay: 14649600 · Pay ratio (CEO : median worker): 168:1Huntsman CORPAbbott Laboratories, CEO total pay: 24157648 · Pay ratio (CEO : median worker): 166:1Abbott LaboratoriesElanco Animal Health Inc, CEO total pay: 14964175 · Pay ratio (CEO : median worker): 181:1Elanco Animal Health IncAmgen Inc, CEO total pay: 24693120 · Pay ratio (CEO : median worker): 160:1Amgen IncQuidelOrtho Corp, CEO total pay: 11290664 · Pay ratio (CEO : median worker): 154:1QuidelOrtho Corp
Cabot Corp vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Cabot Corp's structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Cabot Corp

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
171:1
FY2025
vs prior FY
+13:1
from FY2024 158:1
CEO $ YoY
-3%
$9.3M latest
Filings shown
5
FY2021–2025
Cabot Corp CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $8.2M - $71,871 115:1 -
2022 $7.9M -3.6% $62,661 127:1 +12:1
2023 $7.8M -2% $57,350 136:1 +9:1
2024 $9.6M +23% $60,904 158:1 +22:1
2025 $9.3M -3% $54,397 171:1 +13:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 16040, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
171:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$9.3M
Companies in Industry
168
vs. Industry Median
Above
#19 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Cabot Corp: STEEP · HEAVY pay ratio

Cabot Corp's FY2025 ratio 171:1 ranks #19 of 168 Chemicals & Pharmaceuticals filers (89th percentile). the CEO earned 171× the median employee ($54,397) in FY2025.

Median employee $54,397 (PAR-MED); STEEP · HEAVY stamps put about 171 median-wage years per CEO year.

CEO Total Pay

$9.3M

FY2025 Summary Compensation, above median

Pay Ratio

171:1

Elevated vs. peers

Cabot Corp in the higher Chemicals & Pharmaceuticals third

Cabot Corp's FY2025 ratio 171:1 ranks #19 of 168 Chemicals & Pharmaceuticals filers (89th percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Cabot Corp's $9.3M CEO total is above the $7.9M industry median CEO pay.

Dollar rank #575 and ratio rank #377 split - treat 171:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$9.3M
Median Employee Pay
$54,397
Pay Ratio
171:1
Filing Date
2026-01-27

Company Info

Ticker
CBT
CIK
16040
Industry
Chemicals & Pharmaceuticals
SIC Code
2890
State
DE
View SEC filings →
SEC EDGAR DEF 14A for CIK 16040, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Cabot Corp's FY2025 ratio 171:1 ranks #19 of 168 Chemicals & Pharmaceuticals filers (89th percentile).

Read with Cabot Corp

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps STEEP · HEAVY · PAR-MED.

SPX Technologies, Inc. · HEAVY

ABS(ceo_total_comp) peer at $9.3M (Δ $31K heavier vs Cabot Corp); MID · PAR-MED vs this page's STEEP · HEAVY · PAR-MED.
Option Care Health, Inc. · HEAVY

ABS(ceo_total_comp) peer at $9.3M (Δ $42K lighter vs Cabot Corp); STEEP · PAR-MED vs this page's STEEP · HEAVY · PAR-MED.
Essential Utilities, Inc. · HEAVY

ABS(ceo_total_comp) peer at $9.3M (Δ $46K lighter vs Cabot Corp); MID · HIGH-MED vs this page's STEEP · HEAVY · PAR-MED.
AtriCure, Inc. · HEAVY

ABS(ceo_total_comp) peer at $9.2M (Δ $72K lighter vs Cabot Corp); MODEST · ELITE-MED vs this page's STEEP · HEAVY · PAR-MED.
Huntsman CORP (SIC 28 pole)

Huntsman CORP stamps STEEP · HEAVY nearest in-SIC by ABS(pay_ratio) to Cabot Corp's STEEP filing.
National dual ranks · #575/#377

Cabot Corp's FY2025 package sits #575 by CEO dollars and #377 by ratio under HEAVY · STEEP.
Comp structure · HEAVY

Cabot Corp's HEAVY CEO total is equity-sensitive - read what grant-date fair value does and does not mean.
Data sourced from SEC EDGAR DEF 14A for Cabot Corp (CIK 16040), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.